BioNTech SE - ADR
NASDAQ:BNTX 4:00:00 PM EDT
Business Deals, Products
Biontech And Fosun Pharma To Supply China With MRNA-Based COVID-19 Vaccine
Published: 12/16/2020 08:12 GMT
BioNTech SE - ADR (BNTX) - Biontech and Fosun Pharma to Supply China With Mrna-based Covid-19 Vaccine.
Supply Agreement Reflects Both Companies' Shared Commitment and Efforts to Achieve Vaccine Accessibility and Affordability in China.
Local Phase 2 Clinical Trial of Mrna Covid-19 Vaccine Candidate Bnt162b2 is On-going in Jiangsu, China.
Supply Agreement Reflects Both Companies' Shared Commitment and Efforts to Achieve Vaccine Accessibility and Affordability in China.
Local Phase 2 Clinical Trial of Mrna Covid-19 Vaccine Candidate Bnt162b2 is On-going in Jiangsu, China.